32
total announcements
HCG.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹8,506 Cr
P/E (TTM)
367.5
P/E (Forward)
37.3
EPS (TTM)
₹1.55
52W Low
₹513.30
52W High
₹804.65
Dividend Yield
0.00%
Beta
-0.01
Price / Book
6.2
Debt / Equity
123.1
Revenue (TTM)
₹2,627 Cr
Gross Margin
36.51%
Operating Margin
7.46%
Healthcare Global Enterprises Limited
Healthcare Global Enterprises Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI Regulations, regarding the utilization of Rights Issue proceeds. The report is issued by CARE Ratings Limited and does not contain any deviations from the objects of the issue.
Healthcare Global Enterprises Limited
Healthcare Global Enterprises Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 for the quarter ended June 30, 2026, regarding the utilisation of funds raised through Rights Issue.
Healthcare Global Enterprises Limited
Healthcare Global Enterprises Limited has re-appointed M/s. Rao Murthy & Associates as the Cost Auditor for the financial year 2026-27.
Healthcare Global Enterprises Limited
Healthcare Global Enterprises Limited has informed the Exchange about board approval for further investment of up to INR 16 Crore in HCG Rajkot Hospitals LLP, a wholly owned subsidiary of the Company.
Healthcare Global Enterprises Limited
Healthcare Global Enterprises Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, which include a profit before exceptional items and tax of ₹748 lakhs and a profit for the period of ₹558 lakhs.
Healthcare Global Enterprises Limited
Healthcare Global Enterprises Limited has entered into an agreement to acquire a 26% equity stake in Epic Vighnaharta Renewable Energy Private Limited through the subscription of equity shares for an aggregate consideration of INR 38 lakh.
Healthcare Global Enterprises Limited
Healthcare Global Enterprises Limited has scheduled an earnings conference call on August 7, 2026, to discuss its unaudited financial results for the quarter ended June 30, 2026.
Healthcare Global Enterprises Limited
Healthcare Global Enterprises Limited has informed the Exchange about a special window for transfer and dematerialisation of physical securities which were sold/purchased prior to April 1, 2019, in accordance with SEBI circular no. HO/38/13/11(2)2026-MIRSD-POD/ I/3750/2026 dated January 30, 2026.
Healthcare Global Enterprises Limited
Healthcare Global Enterprises Limited has submitted the Exchange a copy Scrutinizer's report dated July 09, 2026 with respect to the resolutions passed by way of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
Healthcare Global Enterprises Limited
Healthcare Global Enterprises Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialization and rematerialization of securities during the quarter ended June 30, 2026.
Healthcare Global Enterprises Limited
Healthcare Global Enterprises Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Healthcare Global Enterprises Limited
Healthcare Global Enterprises Limited has completed the transfer of 99.999% of its equity shareholding in BACC Health Care Private Limited to Inviga Healthcare Fund I and its nominee, with the initial consideration of INR 28.23 crores received on June 29, 2026.